Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study.EuroIntervention. 2019; 15: e225-e230
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.Lancet. 2009; 374: 534-542
- Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.J Am Coll Cardiol. 2014; 64: 1-12
- Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial.Circulation. 2021; 143: 1754-1762
- Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial.Circulation. 2021; 144: 1543-1552
- 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials.J Am Coll Cardiol. 2017; 70: 2964-2975
- Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials.J Am Coll Cardiol. 2020; 76: 2795-2797
- Outcomes of routine intracardiac echocardiography to guide left atrial appendage occlusion.JACC Clin Electrophysiol. 2020; 6: 393-400
- Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: procedural and cost considerations.Heart Rhythm. 2019; 16: 334-342
- Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion.JACC Cardiovasc Interv. 2020; 13: 277-292
- Left atrial appendage occlusion using intracardiac echocardiography.Heart Rhythm. 2021; 18: 313-317
- First-in-human use of a novel live 3D intracardiac echo probe to guide left atrial appendage closure.JACC Cardiovasc Interv. 2021; 14: 2407-2409
- Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry.JACC Clin Electrophysiol. 2022; 8: 766-778
- Leak closure following left atrial appendage exclusion procedures: a multicenter registry.Catheter Cardiovasc Interv. 2022; 99: 1867-1876
- Feasibility of complex transfemoral electrophysiology procedures in patients with inferior vena cava filters.Heart Rhythm. 2019; 16: 873-878
- Long-term complications of inferior vena cava filters.J Vasc Surg Venous Lymphat Disord. 2017; 5: 33-41
- Successful left atrial appendage closure using a percutaneous hepatic venous approach.HeartRhythm Case Rep. 2019; 5: 545-548
- Three-dimensional transesophageal echocardiography to facilitate transseptal puncture and left atrial appendage occlusion via upper extremity venous access.Circ Arrhythm Electrophysiol. 2015; 8: 988-990
- Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk?.Am Heart J. 2006; 152 (e361–365): 362
- Bailout atrial balloon septoplasty to overcome challenging left atrial transseptal access for catheter ablation of atrial fibrillation.JACC Clin Electrophysiol. 2018; 4: 1011-1019
Funding Sources: The authors have no funding sources to disclose.
Disclosures: Dr Alkhouli reports consulting fees from Boston Scientific , Abbott , Philips , and Johnson & Johnson . Dr Killu reports consulting fees from Boston Scientific , Abbott , and AtriCure; and lecturer fees from Biosense Webster.